CW Analytical Expands Offerings With Orange Photonics Partnership

June 22, 2017

OAKLAND, Calif., June 22, 2017 —CW Analytical Laboratories Inc., a leading laboratory in California’s Cannabis industry, and Orange Photonics Inc, producer of portable Cannabinoid analyzers, are pleased to announce their distribution partnership throughout the state of California.

Utilizing a modified version of the same high pressure liquid chromatography currently used to measure cannabinoid content in a laboratory setting, LightLab™ allows users to evaluate the potency of flowers and extracts from the location of their choosing.

Orange Photonics' LightLab™

“We’re thrilled to finally evaluate a portable analytical machine that measures analytes based upon a reference standard rather than a reference database currently used by portable infrared technologies,” says Dr. Robert Martin, CEO of CW Analytical. “This new machine has passed all of our testing trials with flying colors and is both reliable and affordable. We look forward to creating a new company to offer sales and user support for this exciting technology.”

“Turnaround time is a huge pain point for our clients,” says Emily Richardson, Vice President of Business Development at CW Analytical. “Whether it’s an extractor making a purchasing decision on trim, or a grower refining a breeding program, LightLab™ offers an accurate and affordable way to measure Cannabinoid content on-site, without the time and logistics involved with getting a sample to our lab.”

“We are pleased to work with CW Analytical. Their commitment to analytical excellence and exceptional customer service makes them a natural partner for Orange Photonics,” says Stephanie McArdle, President of Orange Photonics. “Our customers will benefit from CW’s deep understanding of cannabis business operations and the opportunity to boost efficiency by integrating real-time quality control data from LightLab™.”

About CW Analytical Laboratories Inc.:

A pioneer in Cannabis science, CW Analytical was one of the first laboratories of its kind to serve the Cannabis industry. The company was co-founded in 2009 by two scientists who noticed that the medical Cannabis industry in California was lacking the regulatory and quality assurance practices necessary to ensure the availability of clean, safe medicine. CW Analytical’s team of scientists and industry experts has been providing stakeholders in California with important information about the safety, quality, and potency of medical Cannabis products long before any state mandate.

CW Analytical’s commitment to continuous innovation and technical development has led to the achievement of ISO 17025 accreditation, collaborative research, and the procurement of state-of-the-art analytical instruments to keep CW and their clients at the forefront of regulatory compliance.

CW Analytical’s continued success is due to our commitment to providing clients with accurate, affordable data paired with unrivaled customer service. The company’s mission is to enable clients to better serve their patients and compete in the medical Cannabis marketplace with the safest, cleanest, and most consistent medicine in California.